AnGes, Inc. (TYO:4563)
Japan
· Delayed Price · Currency is JPY 68.00
-2.00 (-2.86%)
Apr 28, 2025, 3:30 PM JST
AnGes Revenue
In the year 2024, AnGes had annual revenue of 643.00M JPY with 323.03% growth. AnGes had revenue of 172.00M in the quarter ending December 31, 2024, with 244.00% growth.
Revenue
643.00M
Revenue Growth
+323.03%
P/S Ratio
34.59
Revenue / Employee
11.69M
Employees
55
Market Cap
22.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 643.00M | 491.00M | 323.03% |
| Dec 31, 2023 | 152.00M | 85.00M | 126.87% |
| Dec 31, 2022 | 67.00M | 3.00M | 4.69% |
| Dec 31, 2021 | 64.00M | 25.00M | 64.10% |
| Dec 31, 2020 | 39.00M | -287.00M | -88.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |